drugset / Trial / NCT01257607
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to compare the safety and efficacy of 1% MIM-D3 and 5% MIM-D3 to placebo for the treatment of the signs and symptoms of dry eye.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavilermide | Protein / enzyme biologic | 1 % | Other |
| Subject | Tavilermide | Protein / enzyme biologic | 5 % | Other |